CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-30 | Mahoney Stephen F. President and CEO | Grant or award · Stock Option (Right to Buy) | +1,259,400 | 1,259,400 | ||
| 2023-09-21 | Gheuens Sarah Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-16 | Meisner Lara Chief Legal Officer | Option exercise | +27 | $23.03 | $622 | 29,998 |
| 2023-06-16 | Meisner Lara Chief Legal Officer | Sale | −27 | $28.35 | $765 | 29,971 |
| 2023-06-16 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −28 | 37,453 | ||
| 2023-06-15 | Meisner Lara Chief Legal Officer | Option exercise | +2,269 | $23.03 | $52K | 32,240 |
| 2023-06-15 | Meisner Lara Chief Legal Officer | Sale | −2,269 | $28.02 | $64K | 29,971 |
| 2023-06-15 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −2,269 | 37,481 | ||
| 2023-06-14 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-06-14 | Moses Jennifer K. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-06-14 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-06-14 | Morris Arlene Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-06-06 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +5,126 | $18.51 | $95K | 35,097 |
| 2023-06-06 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −5,126 | $25.02 | $128K | 29,971 |
| 2023-06-06 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,126 | 84,375 | ||
| 2023-06-05 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +499 | $18.51 | $9K | 30,470 |
| 2023-06-05 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −499 | $25.03 | $12K | 29,971 |
| 2023-06-05 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −499 | 89,501 | ||
| 2023-06-02 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +1,875 | $14.00 | $26K | 31,846 |
| 2023-06-02 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −1,875 | $24.21 | $45K | 29,971 |
Page 5 of 10 · 182 trades